Dow Jones

38 778,10

0,00%

DAX

Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Skye Bioscience Inc (QB) (SKYE)
Skye Bioscience Inc (QB) (SKYE) Actualités

SKYE

Skye Bioscience (QB) (SKYE)

Skye Bioscience Inc (QB)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:SKYE

Date	Heure	Source	Titre	Symbole	Société
05/03/2024	01h53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:SKYE	Skye Bioscience Inc (QB)
04/03/2024	22h23	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:SKYE	Skye Bioscience Inc (QB)
04/03/2024	22h18	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:SKYE	Skye Bioscience Inc (QB)
04/03/2024	12h15	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	USOTC:SKYE	Skye Bioscience Inc (QB)
12/02/2024	18h08	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	USOTC:SKYE	Skye Bioscience Inc (QB)
31/01/2024	22h15	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:SKYE	Skye Bioscience Inc (QB)
03/10/2023	22h12	Edgar (US Regulatory)	Form PRE 14C - Other preliminary information statements	USOTC:SKYE	Skye Bioscience Inc (QB)
28/08/2023	22h16	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	USOTC:SKYE	Skye Bioscience Inc (QB)
07/08/2023	22h37	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:SKYE	Skye Bioscience Inc (QB)
31/03/2023	22h35	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:SKYE	Skye Bioscience Inc (QB)
27/03/2023	22h10	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	USOTC:SKYE	Skye Bioscience Inc (QB)
20/03/2023	11h02	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	USOTC:SKYE	Skye Bioscience Inc (QB)
17/03/2023	19h53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:SKYE	Skye Bioscience Inc (QB)
23/02/2023	23h22	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:SKYE	Skye Bioscience Inc (QB)
16/02/2023	23h38	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:SKYE	Skye Bioscience Inc (QB)
09/01/2023	17h28	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	USOTC:SKYE	Skye Bioscience Inc (QB)
20/12/2022	13h31	InvestorsHub NewsWire	Skye Bioscience Receives FDA Authorization of Investigational New Drug Application for SBI-100 OE	USOTC:SKYE	Skye Bioscience Inc (QB)
16/12/2022	13h57	InvestorsHub NewsWire	Skye Bioscience Doses First Cohort of Participants in Phase 1 Clinical Trial of SBI-100 Ophthalmic Emulsion	USOTC:SKYE	Skye Bioscience Inc (QB)
15/11/2022	21h47	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (3/a)	USOTC:SKYE	Skye Bioscience Inc (QB)
14/11/2022	21h20	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:SKYE	Skye Bioscience Inc (QB)
01/09/2022	22h01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:SKYE	Skye Bioscience Inc (QB)
31/01/2022	19h59	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:SKYE	Skye Bioscience Inc (QB)
05/01/2022	19h05	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:SKYE	Skye Bioscience Inc (QB)
10/11/2021	14h57	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:SKYE	Skye Bioscience Inc (QB)
28/09/2021	14h31	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:SKYE	Skye Bioscience Inc (QB)
10/08/2021	12h04	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:SKYE	Skye Bioscience Inc (QB)
17/05/2021	18h24	InvestorsHub NewsWire	Skye Bioscience's THCVHS Demonstrates Superior Therapeutic Benefit Compared to Glaucoma Standard of Care, both as ...cont	USOTC:SKYE	Skye Bioscience Inc (QB)
13/02/2009	22h52	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	USOTC:SKYE	Skye Bioscience Inc (QB)
02/10/2008	17h08	Edgar (US Regulatory)	Skyepharma Plc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)	USOTC:SKYE	Skye Bioscience Inc (QB)
11/02/2008	22h39	Edgar (US Regulatory)	Skyepharma Plc - Amended Statement of Ownership (SC 13G/A)	USOTC:SKYE	Skye Bioscience Inc (QB)